COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites

Cited by papers we hold 9

• Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy · 2022
  No notice
• CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy · 2021
  No notice
• Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome · 2020
  No notice
• Gene correction for SCID-X1 in long-term hematopoietic stem cells · 2019
  Corrected
• Validating the concept of mutational signatures with isogenic cell models · 2018
  No notice
• A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action · 2017
  No notice
• Outbred genome sequencing and CRISPR/Cas9 gene editing in butterflies · 2015
  No notice
• Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing · 2015
  No notice
• Cas9-chromatin binding information enables more accurate CRISPR off-target prediction · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.